Nebivolol Ratiopharm (Nebivolol Hydrochloride)

Nebivolol Hydrochloride, the active ingredient in Nebivolol Ratiopharm, is a beta blocker presented as an oral tablet for oral use. It is used to treat hypertension in adult patients, helping to lower blood pressure and reduce cardiovascular risk.

GNH USA supplies Nebivolol Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets. We ensure consistent batch release, proper documentation, and timely logistics to meet global demand.

Nebivolol is a selective β1‑adrenergic blocker used in the management of hypertension.

Hypertension: reduces systolic and diastolic blood pressure by decreasing heart rate and peripheral vascular resistance.

Nebivolol may be associated with several adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache - Dizziness - Fatigue - Nasal congestion - Nausea

Serious or Rare Side Effects: - Severe bradycardia - Symptomatic hypotension - Heart block - Bronchospasm - Allergic reactions (rash, angioedema) - Elevated liver enzymes

When prescribing Nebivolol, several safety considerations should be observed.

Blood pressure monitoring: regularly assess to ensure therapeutic effect and avoid excessive lowering. Heart rate monitoring: watch for bradycardia, especially in patients with pre‑existing low heart rate. Asthma/COPD caution: use carefully as β‑blockade may exacerbate bronchospasm. Concurrent beta‑blockers: avoid combining with other β‑blockers to prevent additive effects. Abrupt discontinuation: taper gradually to prevent rebound hypertension. Store at ambient temperature: keep in original packaging, protect from moisture and light.

Nebivolol can interact with other medicines, requiring attention to the level of risk.

Major Interactions (Avoid): - Other beta‑blockers: additive cardiac depression. - Calcium channel blockers (verapamil, diltiazem): may increase nebivolol plasma levels. - Potent CYP2D6 inhibitors (paroxetine, fluoxetine): can raise nebivolol concentrations. - Antihypertensives causing additive hypotension (e.g., ACE inhibitors, ARBs) when combined may lead to excessive blood pressure drop.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance hypotensive effect, monitor electrolytes. - NSAIDs: may reduce antihypertensive efficacy. - Digoxin: may require dose adjustment due to heart rate effects.